Flagellin Restricts HIV-1 Infection of Macrophages through Modulation of Viral Entry Receptors and CC Chemokines

被引:0
|
作者
Zhou, Lina [1 ]
Wang, Xu [1 ]
Xiao, Qianhao [1 ]
Khan, Shazheb [1 ]
Ho, Wen-Zhe [1 ]
机构
[1] Temple Univ, Lewis Katz Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19140 USA
来源
VIRUSES-BASEL | 2024年 / 16卷 / 07期
基金
美国国家卫生研究院;
关键词
flagellin; TLR-5; macrophage; HIV-1; CC chemokine; VACCINE; IMMUNITY; AGONIST;
D O I
10.3390/v16071063
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Both bacteria product flagellin and macrophages are implicated in HIV-1 infection/disease progression. However, the impact of their interaction on HIV-1 infection and the associated mechanisms remain to be determined. We thus examined the effect of the flagellins on HIV-1 infection of primary human macrophages. We observed that the pretreatment of macrophages with the flagellins from the different bacteria significantly inhibited HIV-1 infection. The mechanistic investigation showed that the flagellin treatment of macrophages downregulated the major HIV-1 entry receptors (CD4 and CCR5) and upregulated the CC chemokines (MIP-1 alpha, MIP-1 beta and RANTES), the ligands of CCR5. These effects of the flagellin could be compromised by a toll-like receptor 5 (TLR5) antagonist. Given the important role of flagellin as a vaccine adjuvant in TLR5 activation-mediated immune regulation and in HIV-1 infection of macrophages, future investigations are necessary to determine the in vivo impact of flagellin-TLR5 interaction on macrophage-mediated innate immunity against HIV-1 infection and the effectiveness of flagellin adjuvant-based vaccines studies.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] The Interplay of HIV-1 and Macrophages in Viral Persistence
    Hendricks, Chynna M.
    Cordeiro, Thaissa
    Gomes, Ana Paula
    Stevenson, Mario
    [J]. FRONTIERS IN MICROBIOLOGY, 2021, 12
  • [22] Difference in susceptibility to CC-chemokines among HIV-1 isolates
    Gao, M
    Tsuchie, H
    Jin, TQ
    Zhang, J
    Detorio, MA
    Hossain, MM
    Taniguchi, K
    Kurimura, T
    [J]. INTERNATIONAL JOURNAL OF STD & AIDS, 1998, 9 (08) : 471 - 475
  • [23] VIRAL DYNAMICS IN HIV-1 INFECTION
    SHAW, G
    WEI, X
    GHOSH, S
    JOHNSON, V
    DEUTSCH, P
    EMMINI, E
    LIFSON, J
    NOWAK, M
    HAHN, B
    SAAG, M
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 181 - 181
  • [24] Viral dynamics in HIV-1 infection
    Finzi, D
    Siliciano, RF
    [J]. CELL, 1998, 93 (05) : 665 - 671
  • [25] Chemokines join fight against HIV-1 infection
    Morris, K
    [J]. LANCET, 1997, 349 (9058): : 1075 - 1075
  • [26] HIV-1 Uses Dynamic Podosomes for Entry into Macrophages
    Li, Wei
    Liu, Ji
    Liu, Yuanyuan
    Li, Qin
    Yin, Wen
    Wanderi, Kevin K.
    Zhang, Xiaowei
    Zhang, Zhiping
    Zhang, Xian-En
    Cui, Zongqiang
    [J]. JOURNAL OF VIROLOGY, 2021, 95 (10)
  • [27] HIV-1 cell entry and advances in viral entry inhibitor therapy
    Cooley, LA
    Lewin, SR
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2003, 26 (02) : 121 - 132
  • [28] Entry inhibitors in the treatment of HIV-1 infection
    Tilton, John C.
    Doms, Robert W.
    [J]. ANTIVIRAL RESEARCH, 2010, 85 (01) : 91 - 100
  • [29] ISG15 deficiency restricts HIV-1 infection
    Jurczyszak, Denise
    Manganaro, Lara
    Buta, Sofija
    Gruber, Conor
    Martin-Fernandez, Marta
    Taft, Justin
    Patel, Roosheel
    Cipolla, Melissa
    Alshammary, Hala
    Mulder, Lubbertus C. F.
    Sachidanandam, Ravi
    Bogunovic, Dusan
    Simon, Viviana
    [J]. PLOS PATHOGENS, 2022, 18 (03)
  • [30] Ferroportin restricts HIV-1 infection in sickle cell disease
    Kumari, Namita
    Ammosova, Tatiana
    Diaz, Sharmeen
    Oneal, Patricia
    Nekhai, Sergei
    [J]. RETROVIROLOGY, 2016, 13